Show simple item record

dc.contributor.authorComite, Ubaldo
dc.contributor.authorDong, Kechen
dc.contributor.authorLi, Rita Yi Man
dc.contributor.authorCrabbe, M. James C.
dc.contributor.authorShao, Xue-Feng
dc.contributor.authorYue, Xiao-Guang
dc.date.accessioned2020-06-30T10:56:06Z
dc.date.available2020-06-30T00:00:00Z
dc.date.available2020-06-30T10:56:06Z
dc.date.issued2020-06-23
dc.identifier.citationComite U, Dong K, Li RYM, Crabbe MJC, Shao X-F, Yue X-G (2020) 'An economic–business approach to clinical risk management', Journal of Risk and Financial Management, 13 (6), pp.135-146.en_US
dc.identifier.doi10.3390/jrfm13060135
dc.identifier.urihttp://hdl.handle.net/10547/624120
dc.description.abstractThis paper introduces risk factors in the field of healthcare and discusses the clinical risks, identification, risk management methods, and tools as well as the analysis of specific situations. Based on documentary analysis, an ecient and coherent methodological choice of an informative and non-interpretative approach, it relies on “unobtrusive” and “non-reactive” information sources, such that the research results are not influenced by the research process itself. To ensure objective and systematical analysis, our research involved three macro-phases: (a) the first involved a skimming (a superficial examination) of the documents collected; (b) the second reading (a thorough examination) allowed a selection of useful information; (c) the third phase involved classification and evaluation of the collected data. This iterative process combined the elements of content and thematic analysis that categorised the information into di erent categories which were related to the central issues for research purposes. Finally, from the perspective of safety analysis and risk management, we suggest that comprehensive control and operation should be conducted in a holistic way, including patient safety, cost consumption, and organizational responsibility. An organizational strategy that revolves around a constant and gradual risk management process is an important factor in clinical governance which focuses on the safety of patients, operators, and organizations.en_US
dc.language.isoenen_US
dc.publisherMDPIen_US
dc.relation.urlhttps://www.mdpi.com/1911-8074/13/6/135en_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectcoronavirusen_US
dc.subjectrisk managementen_US
dc.subjectclinical risken_US
dc.subjectSubject Categories::L431 Health Policyen_US
dc.titleAn economic–business approach to clinical risk managementen_US
dc.typeArticleen_US
dc.identifier.eissn1911-8074
dc.contributor.departmentUniversity Giustino Fortunatoen_US
dc.contributor.departmentUniversity of South Australiaen_US
dc.contributor.departmentHong Kong Shue Yan Universityen_US
dc.contributor.departmentOxford Universityen_US
dc.contributor.departmentUniversity of Bedfordshireen_US
dc.contributor.departmentShanxi Universityen_US
dc.contributor.departmentUniversity of Sydneyen_US
dc.contributor.departmentRajamangala University of Technology Rattanakosinen_US
dc.contributor.departmentEuropean University Cyprusen_US
dc.contributor.departmentPolitécnico do Portoen_US
dc.contributor.departmentRomanian-American Universityen_US
dc.identifier.journalJournal of Risk and Financial Managementen_US
dc.date.updated2020-06-30T10:49:21Z
dc.description.noteopen access


Files in this item

Thumbnail
Name:
jrfm-13-00135.pdf
Size:
462.6Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 International
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International